Mycodern Spolka Akcyjna Logo

Mycodern Spolka Akcyjna

Producer of functional foods and supplements for manufacturing and distribution.

MCD | WAR

Overview

Corporate Details

ISIN(s):
PLMDNPL00013 (+3 more)
LEI:
25940087YXP4K8ENAO45
Country:
Poland
Address:
GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK

Description

Mycodern Spolka Akcyjna is a producer of functional foods and innovative dietary supplements. The company's product portfolio includes items such as functional gummies and oils. Its business activities encompass contract manufacturing, wholesale, trading, and retail distribution.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 15:26
zal03_FormularzA_-_Flash_Fundacja_Rodzinna.pdf
Polish 77.9 KB
2025-12-22 15:26
zal01_FormularzA_-_J.Wasita.pdf
Polish 75.2 KB
2025-12-22 15:26
zal02_FormularzA_-_M.Pastewska.pdf
Polish 79.5 KB
2025-12-22 15:26
Zawiadomienia akcjonariuszy w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 786 bytes
2025-12-18 14:14
Podpisanie umowy o sprawowanie nadzoru nad przebiegiem postępowania restruktury…
Polish 1.7 KB
2025-12-16 17:01
zal01_FormularzA_1.pdf
Polish 77.8 KB
2025-12-16 17:01
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 467 bytes
2025-12-16 09:18
zal01_FormularzA.pdf
Polish 79.4 KB
2025-12-16 09:18
Zawiadomienie akcjonariusza w trybie art. 69 ustawy o ofercie - Content (PL)
Polish 436 bytes
2024-04-08 15:20
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
Polish 2.1 KB
2024-03-29 20:50
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
Polish 1.5 KB
2024-01-23 23:32
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
Polish 1.2 KB
2024-01-23 23:29
Dokument Ofertowy - MCD
Polish 388.9 KB
2024-01-23 23:29
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
Polish 1.2 KB
2024-01-23 17:20
Zawarcie umowy o współpracy - Content (PL)
Polish 1.7 KB

Automate Your Workflow. Get a real-time feed of all Mycodern Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mycodern Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mycodern Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BELITE BIO, INC Logo
Clinical-stage biopharma developing therapies for retinal and metabolic diseases.
United States of America
BLTE
Benitec Biopharma Inc. Logo
A clinical-stage biotech developing genetic medicines to silence disease-causing genes.
United States of America
BNTC
BeOne Medicines Ltd. Logo
Global oncology company that discovers, develops, and delivers cancer treatments.
United States of America
ONC
BerGenBio Logo
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
Norway
BGBIO
Beximco Pharmaceuticals Ltd. Logo
Manufacturer of generic drugs, APIs, and specialized products for global markets.
Bangladesh
BXP
BeyondSpring Inc. Logo
Clinical-stage biopharma company developing immuno-oncology cancer therapies.
United States of America
BYSI
BGM Group Ltd. Logo
A holding company focused on technology and biopharmaceutical manufacturing.
United States of America
BGM
Bicara Therapeutics Inc. Logo
Clinical-stage biopharma developing dual-action biologics for solid tumors.
United States of America
BCAX
BICYCLE THERAPEUTICS PLC Logo
Clinical-stage biopharma developing a novel class of bicyclic peptide medicines.
United States of America
BCYC
BIFIDO. Co. Ltd Logo
Biotechnology firm developing human-derived Bifidobacterium for various products.
South Korea
238200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.